Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 11/20 | 0.46 |
| ▸ | JAK1 | P23458 | 8/20 | 0.46 |
| ▸ | JAK3 | P52333 | 5/20 | 0.46 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.46 |
| ▸ | TYK2 | P29597 | 3/20 | 0.43 |
| ▸ | STAT6 | P42226 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 5/20 | 0.41 |
| ▸ | WEE1 | P30291 | 2/20 | 0.41 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3716516 | 0.87 | RPS6KA3 (0.47) | JAK2JAK1JAK3RPS6KA3TYK2 | |
| SCHEMBL3721785 | 0.86 | JAK2 (0.46) | JAK2JAK1JAK3RPS6KA3TYK2 | |
| SCHEMBL3714024 | 0.85 | RPS6KA3 (0.48) | JAK2JAK1JAK3RPS6KA3TYK2 | |
| SCHEMBL3716698 | 0.81 | JAK2 (0.67) | JAK2JAK1JAK3RPS6KA3TYK2 | |
| SCHEMBL15163170 | 0.81 | TBK1 (0.49) | JAK2JAK1JAK3RPS6KA3TYK2 | |
| SCHEMBL1284228 | 0.79 | TBK1 (0.63) | JAK2JAK1JAK3 | |
| SCHEMBL3714457 | 0.79 | JAK1 (0.58) | JAK2JAK1JAK3TYK2HDAC6 | |
| SCHEMBL3715005 | 0.78 | PTK2 (0.46) | JAK2JAK1JAK3RPS6KA3TYK2 | |
| SCHEMBL3713912 | 0.78 | MAP3K5 (0.54) | JAK2JAK1JAK3RPS6KA3TYK2 | |
| SCHEMBL15163477 | 0.78 | CDK4 (0.53) | JAK2JAK1JAK3RPS6KA3TYK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2403853-B1 | PYRROLOPYRIMIDINES USED AS KINASE INHIBITORS | MEDICAL RES COUNCIL TECHNOLOGY (GB) | 2013-08-14 | — | — | EP | claimed |
| WO-2010100431-A1 | PYRROLOPYRIMIDINES USED AS KINASE INHIBITORS | MEDICAL RESEARCH COUNCIL TECHNOLOGY (GB) | 2010-09-10 | — | — | WO | claimed |
| EP-2403853-B1 | PYRROLOPYRIMIDINES USED AS KINASE INHIBITORS | MEDICAL RES COUNCIL TECHNOLOGY (GB) | 2013-08-14 | — | — | EP | disclosed |
| WO-2010100431-A1 | PYRROLOPYRIMIDINES USED AS KINASE INHIBITORS | MEDICAL RESEARCH COUNCIL TECHNOLOGY (GB) | 2010-09-10 | — | — | WO | disclosed |